Enovis Corp. (ENOV)
24.59
-1.87
(-7.07%)
USD |
NYSE |
May 21, 16:00
24.59
0.00 (0.00%)
After-Hours: 19:59
Enovis Research and Development Expense (TTM) : 123.34M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Integra LifeSciences Holdings Corp. | 68.30M |
| Globus Medical, Inc. | 150.48M |
| Abbott Laboratories | 2.954B |
| AngioDynamics, Inc. | 27.86M |
| Accuray, Inc. | 41.57M |